Trials / Completed
CompletedNCT02542410
Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- Female
- Age
- 15 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The proposed pilot study will estimate the efficacy and safety of a novel therapeutic agent, cabergoline, with a clinical standard therapy, norethindrone acetate, for the treatment of endometriosis-associated pain in young women with endometriosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cabergoline | |
| DRUG | Norethindrone acetate |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2015-09-07
- Last updated
- 2020-02-05
- Results posted
- 2020-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02542410. Inclusion in this directory is not an endorsement.